No Data
No Data
Myriad Genetics Price Target Cut to $6.00/Share From $22.00 by Wells Fargo
A Quick Look at Today's Ratings for Myriad Genetics(MYGN.US), With a Forecast Between $10 to $18
Earnings Release: Here's Why Analysts Cut Their Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target To US$10.54
Wolfe Research Downgrades Myriad Genetics to Peer Perform From Outperform
Express News | Myriad Genetics, Inc. : Wells Fargo Cuts Target Price to $6 From $22
Hold Rating Maintained for Myriad Genetics Amid Revenue Cuts and Strategic Uncertainty